ESR1 and breast cancer: Despite the National Comprehensive Cancer Network (NCCN) guidelines recommending ALND in the setting of > 3 positive lymph nodes in patients with breast cancer undergoing upfront surgery, national rates for ALND have decreased in patients with pT0–T2 ER+ HER− breast cancer and 3–5 positive lymph nodes.